J&J Covid-19 Vaccine Is 66% Effective in Global Clinical Trial January 30, 2021 Unipro2013main Entertainment Health and WellBeing Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign. Credit Bloomberg Quicktake: Now Please support our Sponsors here :